Share

Comments on:

Pfizer still wants AstraZeneca after $98.7 billion bid rejected

Back to the article » |
Pfizer Inc. proposed buying AstraZeneca Plc for about $98.7 billion in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. Pfizer offered 46.61 pounds a share in cash and stock for London-based AstraZeneca last January, and AstraZeneca declined to pursue negotiations, New York-based company Pfizer said in a statement...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.